SLNO Live signals | Maximize Profits with Getagraph.com

SELL 92842 min ago

@ $47.17

Issued: 14 Feb 2024 @ 13:07

Return: -21.24%

Previous signal: Feb 12 - 13:41

Previous signal: Buy

Return: -2.41 %

Live Chart Being Loaded With Signals

Commentary (18 Apr 2024 @ 16:00):

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases...

Stats
Today's Volume	210 969
Average Volume	303 348
Market Cap	1.21B
EPS	$0 ( 2024-03-19 )
Next earnings date	( $-0.270 ) 2024-05-07
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-15.74
ATR14	$0.0550 (0.15%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-01	Yen Kristen	Sell	1 330	Common Stock
2024-04-01	Yen Kristen	Sell	888	Common Stock
2024-04-01	Mackaness James H	Sell	3 104	Common Stock
2024-04-01	Mackaness James H	Sell	2 071	Common Stock
2024-04-01	Hirano Patricia C	Sell	888	Common Stock

INSIDER POWER
6.43
Last 99 transactions
Buy: 11 271 770 \| Sell: 9 891 855

Volume Correlation

Long: -0.17 (neutral)

Short: -0.76 (moderate negative)

Signal:(34.376) Neutral

Soleno Therapeutics Inc Correlation

10 Most Positive Correlations
CVV	0.937
MDGL	0.929
EWCZ	0.928
EVCM	0.925
BNFT	0.92
DGHI	0.918
KIN	0.917
RIGL	0.912
EXFO	0.912
GIGM	0.912

10 Most Negative Correlations
RIVN	-0.913
SOPA	-0.912
LUCD	-0.911
SNPX	-0.906
MTEX	-0.905
PIII	-0.902
OP	-0.899
SMMF	-0.898
ZENV	-0.889
JAN	-0.886

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Soleno Therapeutics Inc Correlation - Currency/Commodity

0.00
( neutral )

-0.51
( weak negative )

-0.48
( neutral )

0.10
( neutral )

Soleno Therapeutics Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-1.96M (0.00 %)
EPS:	$-2.36

Q4	2023
Revenue:	$0
Gross Profit:	$-489 000 (0.00 %)
EPS:	$-0.330

Q3	2023
Revenue:	$0
Gross Profit:	$-557 000 (0.00 %)
EPS:	$-0.950

Q2	2023
Revenue:	$0
Gross Profit:	$-598 000 (0.00 %)
EPS:	$-0.810

Financial Reports:

No articles found.

Soleno Therapeutics Inc

Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing Phase III clinical development program. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.